Teva announces FDA approval of QVAR RediHaler (beclomethasone dipropionate HFA) inhalation aerosol

9th August 2017 Uncategorised 0

Teva Pharmaceutical Industries

More: Teva announces FDA approval of QVAR RediHaler (beclomethasone dipropionate HFA) inhalation aerosol
Source: MDlinx